The complications of the little boy’s genetic skin disease grew as he did. Tiny blisters had covered his back as a newborn. Then came the chronic skin wounds that extended from his buttocks down to his legs.
By June 2015, at age 7, the boy had lost nearly two-thirds of his skin due to an infection related to the genetic disorder junctional epidermolysis bullosa, which causes the skin to become extremely fragile. There’s no cure for the disease, and it is often fatal for kids. At the burn unit at Children’s Hospital in Bochum, Germany, doctors offered him constant morphine and bandaged much of his body, but nothing — not even his father’s offer to donate his skin — worked to heal his wounds.
“We were absolutely sure we could do nothing for this kid,” Dr. Tobias Rothoeft, a pediatrician with Children’s Hospital in Bochum, which is affiliated with Ruhr University. “[We thought] that he would die.”
SEE ALSO: Could Scientists Engineer Hearts for Organ Transplants?As a last-ditch effort, the boy’s father asked if there were any available experimental treatments. The German doctors reached out to Dr. Michele De Luca, an Italian stem cell expert who heads the Center for Regenerative Medicine at the University of Modena and Reggio Emilia, to see if a transplant of genetically modified skin cells might be possible. De Luca knew the odds were against them — such a transplant had only been performed twice in the past, and never on such a large portion of the body. But he said yes.
The doctors were ultimately able to reconstruct fully functional skin for 80 percent of the boy’s body by grafting on genetically modified cells taken from the boy’s healthy skin. The researchers say the results of this single-person clinical trial, published on Wednesday in Nature, show that transgenic stem cells can regenerate an entire tissue. De Luca told reporters the procedure not only offers hope to the 500,000 epidermolysis bullosa patients worldwide — but also could offer a blueprint for using genetically modified stem cells to treat a variety of other diseases.
To cultivate replacement skin, the medical team took a biopsy the size of a matchbook from the boy’s healthy skin and sent it to De Luca’s team in Italy. There, researchers cloned the skin cells and genetically modified them to have a healthy version of the gene LAMB3, responsible for making the protein laminin-332. They grew the corrected cultures into sheets, which they sent back to Germany. Then, over a series of three operations between October 2015 and January 2016, the surgical team attached the sheets on different parts of the boy’s body.
The gene-repaired skin took, and spread. Within just a month the wounds were islands within intact skin. The boy was sent home from the hospital in February 2016, and over the next 21 months, researchers said his skin healed normally. Unlike burn patients — whose skin grafts aren’t created from genetically modified cells — the boy won’t need ointment for his skin and can regrow his hair.
The gene-repaired skin took, and spread. Within just a month the wounds were islands within intact skin.
And unlike simple grafts of skin from one body part to another, “we had the opportunity to reproduce as much as those cells as we want,” said plastic surgeon Dr. Tobias Hirsch, one of the study’s authors. “You can have double the whole body surface or even more. That’s a fantastic option for a surgeon to treat this child.”
Dr. John Wagner, the director of the University of Minnesota Masonic Children’s Hospital’s blood and marrow transplant program, told STAT the findings have “extraordinary” potential because, until now, the only stem cell transplants proven to work in humans was of hematopoietic stem cells — those in blood and bone marrow.
“They’ve proven that a stem cell is engraftable,” Wagner said. “In humans, what we have to demonstrate is that a parent cell is able to reproduce or self-renew, and differentiate into certain cell populations for that particular organ. This is the first indication that there’s another stem cell population [beyond hematopoietic stem cells] that’s able to do that.”
SEE ALSO: Q&A: Turning to stem cells to restore visionThe researchers said the aggressive treatment outlined in the study — necessary in the case of the 7-year-old patient — could eventually help other patients in less critical condition. One possibility, they noted in the paper, was to “bank” skin samples from infants with JEB before they develop symptoms. These could then be used to treat skin lesions as they develop rather than after they become life-threatening.
“The treatment might be more effective in children, whose stem cells have higher renewal potential and who have less total skin to replace, than in adults,” Mariaceleste Aragona and Cédric Blanpain, stem cell researchers with the Free University of Brussels, wrote in an accompanying commentary for Nature.
But De Luca said more research must be conducted to see if the methods could be applied beyond this specific genetic disease. His group is currently running a pair of clinical trials in Austria using genetically modified skin stem cells to treat another 12 patients with two different kinds of epidermolysis bullosa, including JEB.
For the 7-year-old boy, life has become more normal now that it ever was before, the researchers said. He’s off pain meds. While he has some small blisters in areas that didn’t receive a transplant, they haven’t stopped him from going to school, playing soccer, or behaving like a healthy child.
“The kid is doing quite well. If he gets bruises like small kids [do], they just heal as normal skin heals,” Rothoeft said. “He’s quite healthy.”
Copyright © 2023 Powered by
Amazing stem cell treatment healed a lethal skin disease-拍板定案网
sitemap
文章
2262
浏览
27
获赞
54831
Dude gets caught eating pizza live on camera outside the Cohen hearing
Have you spent all day watching the Cohen hearing, becoming more exhausted with each passing moment?NVIDIA CEO Jensen Huang proclaims Greater Bay Area’s tech edge at HKUST ceremony · TechNode
NVIDIA founder Jensen Huang attended the 2024 Honorary Doctorate Conferment Ceremony at the Hong KonTencent opens beta recruitment for Final Fantasy XIV: Crystal World · TechNode
Chinese tech firm Tencent announced Thursday that it has begun recruiting participants for the betaSF Holding lists on Hong Kong Stock Exchange · TechNode
Chinese delivery services and logistics company SF Holding Co., Ltd. was officially listed on the HoThis massive fried rice prank turned into a great Photoshop battle
Twitter has always loved to ride the wave of internet culture. And this wave is certainly a big one.Chinese sports tech firm Keep cuts workforce by 10
Keep, a Chinese sports tech company, began layoffs last week, cutting 10-15% of its workforce, accorChina and EU nearing agreement on import tariffs on Chinese EVs: report · TechNode
China and the European Commission are nearing agreement on additional duties imposed on Chinese elecSamsung invests $15.2 million to expand semiconductor packaging at Suzhou plant · TechNode
Samsung is increasing its investment in domestic and overseas production facilities to enhance its aDyson's V11 Torque Drive is 20 percent more powerful than Cyclone V10
The future of vacuuming is cordless.A year after halting all new designs of its wired stand-up vacuuKey executives depart as Baidu restructures healthcare division · TechNode
Baidu executive He Mingke, who led the company’s Health Care Group (HCG) as a senior vice president,JD.com reports 5.1% revenue growth in Q3 2024 · TechNode
JD.com, Inc. reported a 5.1% year-on-year increase in net revenues, reaching RMB 260.4 billion ($36NXP to establish a China
The semiconductor company VSMC, a joint venture between Dutch chip giant NXP and Taiwan’s VangStephen King apparently owns a Tesla and Elon Musk is very proud
The king of horror has apparently gone electric. On Sunday, Stephen King tweeted to Elon Musk, telliSenseTime completes strategic restructuring to focus on AI cloud and vision · TechNode
Hong Kong-listed artificial intelligence company SenseTime announced a strategic restructuring in anBaidu reports Q3 revenue dip, AI Cloud growth remains strong · TechNode
Baidu Inc. reported its Q3 2024 earnings on Thursday, showing revenue of RMB 33.6 billion ($4.78 bil